Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation
Top Cited Papers
- 31 July 2007
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 28 (7) , 316-325
- https://doi.org/10.1016/j.tips.2007.05.003
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The clinical significance of ‘small’ effects of smoking cessation treatmentsAddiction, 2007
- Nicotine addiction and comorbidity with alcohol abuse and mental illnessNature Neuroscience, 2005
- Nicotinic modulation of neuronal networks: from receptors to cognitionPsychopharmacology, 2005
- Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humansTrends in Pharmacological Sciences, 2005
- The neurobiology of tobacco dependence: A preclinical perspective on the role of the dopamine projections to the nucleusNicotine & Tobacco Research, 2004
- Extinguishing the rewarding value of smoke cues: Pharmacological and behavioral treatmentsNicotine & Tobacco Research, 2004
- The neurobiology of nicotine addiction: bridging the gap from molecules to behaviourNature Reviews Neuroscience, 2004
- New treatments for smoking cessation.CA: A Cancer Journal for Clinicians, 2000
- The neurobiology of tobacco addictionTrends in Pharmacological Sciences, 1991
- Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gumClinical Pharmacology & Therapeutics, 1988